Xiaoyang Li
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 36
- Protein Degradation and Inhibitors 23
- DNA and Nucleic Acid Chemistry 5
- Epigenetics and DNA Methylation 5
- Advanced biosensing and bioanalysis techniques 4
- Oncology top 5%
- Peptidase Inhibition and Analysis 24
- Organic Chemistry top 5%
- Toxicology top 5%
- Biomaterials top 10%
- Supramolecular Self-Assembly in Materials 7
-
- MicroRNA in disease regulation 5
- Co-authors
- C. James ChouJesse J. McClureWenfang XuYingjie ZhangYuqi JiangElizabeth S. InksJie ZangYuping Jia
- Journals
- Proceedings of the National Academy of Sciences (2 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Physical Chemistry B (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaoyang Li
105 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.3k
- Oncology 497
- Organic Chemistry 443
- Toxicology 38
- Biomaterials 123
Countries citing papers authored by Xiaoyang Li
This map shows the geographic impact of Xiaoyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Li more than expected).
Fields of papers citing papers by Xiaoyang Li
This network shows the impact of papers produced by Xiaoyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Li. The network helps show where Xiaoyang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 6 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 29 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 0 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 16 | |
| 19 | 2020 | 26 | |
| 20 | 2011 | 1 |
About Xiaoyang Li
Xiaoyang Li is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 113 papers that have together received 1.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (36 papers), Peptidase Inhibition and Analysis (24 papers), Protein Degradation and Inhibitors (23 papers), Supramolecular Self-Assembly in Materials (7 papers), DNA and Nucleic Acid Chemistry (5 papers), MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Oncology (497 citations) and Organic Chemistry (443 citations). Xiaoyang Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include C. James Chou, Jesse J. McClure, Wenfang Xu, Yingjie Zhang, Yuqi Jiang, Elizabeth S. Inks, Jie Zang, Yuping Jia, Aixin Song and Jingcheng Hao. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.